A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept

With the introduction of aflibercept, eyes with neovascular age-related macular degeneration (AMD) not responding well to injections of ranibizumab or bevacizumab can be switched to treatment with aflibercept. We carried out a meta-analysis to analyze all available evidence of visual and anatomical...

Descripción completa

Detalles Bibliográficos
Autores principales: Seguin-Greenstein, Sophie, Lightman, Sue, Tomkins-Netzer, Oren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799814/
https://www.ncbi.nlm.nih.gov/pubmed/27042342
http://dx.doi.org/10.1155/2016/4095852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799814/
https://www.ncbi.nlm.nih.gov/pubmed/27042342
http://dx.doi.org/10.1155/2016/4095852

Ejemplares similares